Science Corporation implants PRIMA vision-restoring chip in first Stargardt disease patient

Science Corporation has successfully implanted its PRIMA vision-restoring chip into its first patient suffering from Stargardt disease, which leads to the gradual loss of central vision. The procedure took place at the Sydney Eye Hospital, marking a significant step in the company's efforts to develop brain-computer interface technologies for medical applications. The device aims to restore vision by simulating photoreceptor function in the eye.